Search - tctmd.com

Displaying 161 - 180 of 1171

Sort: Relevancy | Date

News Conference News ESC 2022

GRACE 3.0: Women With NSTE ACS Get a Boost From Updated Score

Caitlin E. Cox

September 06, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

Presentation ESC 2022

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

Presenter: John H. Alexander

August 28, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Conference News ESC 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Todd Neale

August 28, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Yael L. Maxwell

June 03, 2022

News Conference News EAS 2022

Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively

Michael O'Riordan

May 27, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

News Daily News

Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI

Michael O'Riordan

May 13, 2022

News Daily News

Acute MI Workup in Emergency Departments Varies by Sex and Race

Michael O'Riordan

May 11, 2022

News Daily News

Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS

Caitlin E. Cox

May 10, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

Advertisement

GRACE 3.0: Women With NSTE ACS Get a Boost From Updated Score

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Polypill Bests Usual Care in Patients With Recent MI: SECURE

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI

Acute MI Workup in Emergency Departments Varies by Sex and Race

Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS

Good News and Bad for High-Intensity Statin Use in ASCVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content